Primary Site >> Liver Cancer
Gene >> SYNE2
| 1. | |||||||||||
| Journal: | Int J Mol Med. 2014 Dec;34(6):1599-605. | ||||||||||
| Title: | miR96 functions as a tumor suppressor gene by targeting NUAK1 in pancreatic cancer. | ||||||||||
| Author: | Huang, Xuan|Lv, Wei|Zhang, Jian-Hua|Lu, Da-Lin | ||||||||||
| PMID: | 25242509 | ||||||||||
| 2. | |||||||||||
| Journal: | Sci Rep. 2016 Aug 9;6:31237. | ||||||||||
| Title: | EGFR and SYNE2 are associated with p21 expression and SYNE2 variants predict post-operative clinical outcomes in HBV-related hepatocellular carcinoma. | ||||||||||
| Author: | Han, Chuangye|Liao, Xiwen|Qin, Wei|Yu, Long|Liu, Xiaoguang|Chen, Gang|Liu, Zhengtao|Lu, Sicong|Chen, Zhiwei|Su, Hao|Zhu, Guangzhi|Lu, Zili|Liu, Zhiming|Qin, Xue|Gui, Ying|Mo, Zengnan|Li, Lequn|Peng, Tao | ||||||||||
| PMID: | 27502069 | ||||||||||